Proxen in the treatment of gonarthrosis. A controlled clinical double-blind study.
Forty patients of both sexes, aged between 25 and 65 years and suffering from gonarthrosis, took part in a controlled double-blind study of Proxen vs naproxen. Proxen was administered to 20 patients and the control drug to the other 20, in doses of 500 mg twice a day for 60 days. Both drugs demonstrated a good level of activity and tolerance. Proxen proved effective in 94% of the cases, while naproxen was effective in 80%.